<p>Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.</p>

Paul Hagerman discusses a Review which highlights the latest clinical and molecular understanding of the FMR1 mutation and FXTAS.

The Lancet Neurology: July 11, 2013

The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.

Share The Lancet Neurology: July 11, 2013

Sign up to save your podcasts

The Lancet Neurology: July 11, 2013

The Lancet Neurology: July 11, 2013